Search Results

Synapse Biomedical, Inc. announced today that the FDA has granted premarket approval (PMA) of the NeuRx® Diaphragm Pacing System (NeuRx DPS®) for use in patients with spinal cord injuries who rely on mechanical ventilation.

Clearside Biomedical, Inc. announced that multiple oral presentations were delivered at the Clinical Trials at the Summit Meeting on June 8, 2024 in Park City, Utah.

Lifecore Biomedical, Inc. announced it has reached a cooperation agreement with 22NW, LP, which provides for the addition of Humberto Antunes, Jason Aryeh, Paul Johnson and Matthew Korenberg to the Board of Directors of the Company effective immediately following the 2023 Annual Meeting of Stockholders.

Neurocentria Inc., a privately held late-stage biotechnology company developing novel therapies for Alzheimer’s disease, Attention Deficit Hyperactivity Disorder, Major Depressive Disorder and other neurodegenerative and neuropsychiatric disorders, has published a novel research paper identifying magnesium’s key role in synaptic and cognition regulation.